To the full analysis
Buyback calculator for GSK
GSK stock: key metrics
GSKGSK had an operating margin of 24.3% and a return on invested capital (ROIC) of 23.8% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 78.4% | 31.0% | 23.2% |
| 2007 | 77.1% | 34.9% | 23.0% |
| 2008 | 73.7% | 29.3% | 18.9% |
| 2009 | 74.0% | 29.7% | 19.5% |
| 2010 | 72.2% | 13.3% | 5.8% |
| 2011 | 72.1% | 28.5% | 19.2% |
| 2012 | 70.0% | 27.6% | 17.0% |
| 2013 | 67.6% | 26.5% | 20.5% |
| 2014 | 68.2% | 15.6% | 12.0% |
| 2015 | 63.0% | 43.1% | 35.2% |
| 2016 | 66.7% | 9.3% | 3.3% |
| 2017 | 65.7% | 13.5% | 5.1% |
| 2018 | 66.8% | 17.8% | 11.8% |
| 2019 | 64.9% | 20.6% | 13.8% |
| 2020 | 67.4% | 24.6% | no data |
| 2021 | 66.9% | 17.6% | no data |
| 2022 | 67.4% | 21.9% | no data |
| 2023 | 71.8% | 22.2% | 16.2% |
| 2024 | 71.2% | 12.8% | 8.2% |
| 2025 | 72.4% | 24.3% | 17.5% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 57.4% | 41.9% | 21.1% |
| 2007 | 54.4% | 41.1% | 16.8% |
| 2008 | 58.0% | 30.5% | 11.7% |
| 2009 | 55.3% | 32.1% | 12.9% |
| 2010 | 18.4% | 11.5% | 3.9% |
| 2011 | 65.5% | 30.5% | 12.8% |
| 2012 | 77.4% | 26.8% | 10.8% |
| 2013 | 77.7% | 28.9% | 12.9% |
| 2014 | 64.6% | 17.3% | 6.8% |
| 2015 | 164.7% | 42.3% | 15.8% |
| 2016 | 81.1% | 7.5% | 1.5% |
| 2017 | −100.0% | 14.3% | 2.7% |
| 2018 | 95.8% | 21.8% | 6.2% |
| 2019 | 30.7% | 14.0% | 4.4% |
| 2020 | no data | 10.2% | no data |
| 2021 | no data | 7.6% | no data |
| 2022 | no data | 14.2% | no data |
| 2023 | 29.0% | 24.7% | 6.6% |
| 2024 | 18.8% | 13.4% | 4.3% |
| 2025 | 35.0% | 23.8% | 9.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = £0.7544)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 13 Nov 2026, previously Strong
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.